Movano Health Provides Update On FDA Review Of EvieMED Ring, Receives Additional Questions In Final Phase Of 510(k) Application; Remains Optimistic On Clearance After Resolution Of Initial Wellness Features
Portfolio Pulse from Benzinga Newsdesk
Movano Health has provided an update on the FDA review of its EvieMED Ring, stating that it has received additional questions in the final phase of its 510(k) application. The company remains optimistic about obtaining clearance after addressing initial wellness features.
October 10, 2024 | 12:03 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Movano Health is in the final phase of the FDA's 510(k) review for its EvieMED Ring, having received additional questions. The company is optimistic about clearance after resolving initial wellness features.
The news indicates that Movano Health is in the final phase of FDA review for its EvieMED Ring, which is crucial for its market entry. The receipt of additional questions suggests potential delays, but the company's optimism about clearance after resolving initial issues provides a neutral short-term outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100